Butylthio[2.2.2] (NNC 11-1053/LY297802): An orally active muscarinic agonist analgesic

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 876-883

  Swedberg, Michael D B ^a   Sheardown, Malcolm J ^a   Sauerberg, Per ^a   Olesen, Preben H ^a   Suzdak, Peter D ^a   Hansen, Kristian T ^a   Bymaster, Frank P ^b   Ward, John S ^b   Mitch, Charles H ^b   Calligaro, David O ^b   Delapp, Neil W ^b   Shannon, Harlan E ^b  

^a NOVO NORDISK A S   (Denmark)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL)QUINUCLIDINE; METHYLSCOPOLAMINE; MORPHINE; MORPHINE SULFATE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NALTREXONE; OXOTREMORINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; HOT PLATE TEST; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RAT; SALIVATION; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; TREMOR; WRITHING TEST;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; CHOLINERGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MORPHINE; RATS; THIADIAZOLES;

EID: 8244235143     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 75-79, 1941.
2. EDDY, N. B. AND LAMBACH, D.: Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107: 385-393, 1953.
3. FLODMARK, S. AND WRAMNER, T.: The analgetic action of morphine, eserine and prostigmine studied by a modified Hardy-Wolff-Goodell method. Acta Physiol. Scand. 9: 88-96, 1945.
4. GREEN, P. G. AND KITCHEN, I.: Antinociception opioids and the cholinergic system. Prog. Neurobiol. 26: 119-146, 1986.
5. HARRIS, L. S., DEWEY, W. L., HOWES, J. F., KENNEDY, J. S. AND PARS, H.: Narcotic-antagonist analgesics: interactions with cholinergic systems. J. Pharmacol. Exp. Ther. 169: 17-22, 1969.
6. HARTVIG, P., GILLBERG, P. G., GORDH, T., JR. AND POST, C.: Cholinergic mechanisms in pain and analgesia. Trends Pharmacol. Sci. 10: suppl., 75-79, 1989.
7. HELLER BROWN, J.: Atropine, scopolamine and related antimuscarinic drugs. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. Goodman Gilman, T. W. Rall, A. S. Nies and P. Taylor, pp. 150-165, Pergamon Press, New York, 1990.
8. IWAMOTO, E. T. AND MARION, L.: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther. 266: 329-338, 1993.
9. JAFFE, J. H. AND MARTIN, W. R.: Opioid analgesics and antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. Goodman Gilman, T. W. Rall, A. S. Nies and P. Taylor, pp. 485-521, Pergamon Press, New York, 1990.
10. OLESEN, P. H., SAUERBERG, P., TREPPENDAHL, S., LARSSON, O., SHEARDOWN, M. J., SUZDAK, P. D., MITCH, C. H., WARD, J. S., BYMASTER, F. P., SHANNON, H. E. AND SWEDBERG, M. D. B.: 3-(3-Alkylthio-1,2,5-thiadiazol-4-yl)1-azabicycle. Structure-activity relationships for antinociception mediated by central muscarinic receptors. Eur. J. Med. Chem. 31: 221-230, 1996.
11. PETERSON, J., GORDH, T. E., HARTVIG, P. AND WIKLUND, L.: A double-blind trial of the analgesic properties of physostigmine in postoperative patients. Acta Anaesthesiol. Scand. 30: 283-288, 1986.
12. PLEUVRY, B. J. AND TOBIAS, M. A.: Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Br. J. Pharmacol. 43: 706-714, 1971.
13. SAUERBERG, P., OLESEN, P. H., SHEARDOWN, M. J., SUZDAK, P. D., SHANNON, H. E., BYMASTER, F. P., CALLIGARO, D. O., MITCH, C. H., WARD, J. S. AND SWEDBERG, M. D. B.: Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs. Life Sci. 56: 807-814, 1995.
14. SHANNON, H. E., SHEARDOWN, M. J., BYMASTER, F. P., CALLIGARO, D. O., DELAPP, N. W., GIDDA, J., MITCH, C. H., SAWYER, B. D., STENGEL, P. W., WARD, J. S., WONG, D. T., OLESEN, P. H., SUZDAK, P. D., SAUERBERG, P. AND SWEDBERG, M. D. B.: Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): A novel analgesic with mixed muscarinic receptor agonist and antagonist activity. J. Pharmacol. Exp. Ther. 281: 884-894, 1997.
15. 1 receptor agonist activity is not a requirement for muscarinic antinociception. J. Pharmacol. Exp. Ther. 281: 868-875, 1997.
16. SWEDBERG, M. D. B., SHEARDOWN, M. J., SAUERBERG, P., OLESEN, P., SUZDAK, P. D., SHANNON, H. E., BYMASTER, F. P., WARD, J. S., MITCH, C. H. AND CALLIGARO, D. O.: Muscarinic analgesia is mediated by Non-M1 muscarinic receptors (Abstract). Life Sci. 52: 594-594, 1993.
17. SWEDBERG, M. D. B.: The mouse grid-shock analgesia test: Pharmacological characterization of latency to vocalization threshold as an index of antinociception. J. Pharmacol. Exp. Ther. 269: 1021-1028, 1994.
18. SWEDBERG, M. D. B., JACOBSEN, P. AND HONORE, T.: Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX). J. Pharmacol. Exp. Ther. 274: 1113-1121, 1995a.
19. SWEDBERG, M. D. B., SHEARDOWN, M. J., SAUERBERG, P., OLESEN, P. H., SUZDAK, P. D., BYMASTER, F. P., WARD, J. S., MITCH, C. H., CALLIGARO, D. O. AND SHANNON, H. E.: NNC 11-1053/LY 297802: An antinociceptive orally acting muscarinic agonist in mouse and rat (Abstract). Life Sci. 56: 1047-1047, 1995b.
20. WARD, S. J. AND TAKEMORI, A. E.: Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J. Pharmacol. Exp. Ther. 224: 025-530, 1983.